Publication | Closed Access
Natural product toosendanin reverses the resistance of human breast cancer cells to adriamycin as a novel PI3K inhibitor
57
Citations
29
References
2018
Year
Breast OncologyNovel Pi3k InhibitorMedicinePharmacologyBreast CancerPharmacotherapyAnti-cancer AgentCancer TreatmentNatural Product ToosendaninOncologyCell BiologyCancer ResearchDrug Discovery
| Year | Citations | |
|---|---|---|
Page 1
Page 1